Pulsatile drug delivery system for treating morning akinesia

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11975104
APP PUB NO 20190290587A1
SERIAL NO

16316698

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herewith is a pharmaceutical composition comprising, separately or together, a pulsatile release component comprising levodopa and a DOPA decarboxylase inhibitor for the management of OFF-time episodes in patients with Parkinson's disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CONTERA PHARMA A/SVENLIGHEDSVEJ 4 2970 HØRSHOLM 2970

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fullerton, Ann Vivian Copenhagen K, DK 2 9
Højgaard, Bent Allerød, DK 18 20
Hansen, John Bondo Copenhagen Ø, DK 33 228
Nielsen, Peter Gudmund Værløse, DK 3 2
Thomsen, Mikael Søndergård Hvidovre, DK 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 7, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 7, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 7, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00